Inaugural Grants Round
Over 42,000 people are diagnosed with bowel cancer every year in the UK and one million live with other life-changing and longstanding bowel conditions such as the inflammatory bowel diseases – Crohn’s disease and ulcerative colitis – and the incontinence sometimes induced in childbirth. The need to understand the risk factors and potential causes, as well as identifying new ways to diagnose, treat, and manage them has never been more urgent.
By investing in world-class, innovative research and the next generation of researchers, Bowel Research UK aims to support people affected by bowel diseases to live longer and to improve their quality of life.
To mark the launch of Bowel Research UK, the charity is seeking high-quality applications for consideration in its Winter 2020 funding round. Awards of up to £50,000 are available for time-limited (indicatively 12-24 months) proof-of-principle studies based on sound hypotheses. Successful applicants will be expected to make a strong case for how the funding sought will benefit patients and be used to lever further funding to continue the resulting work.
Proposals can relate to any aspect of bowel disease and may vary in stage from basic science through to clinical trials, noting that all studies must have a tangible translational component. Areas of interest include, but are not limited to:
- Colorectal cancer
- Inflammatory Bowel Disease (colitis and Crohn’s disease)
- Benign proctology
- Functional problems (constipation, incontinence)
- Stoma prevention/improvement in quality of life
In addition, specific applications are also sought for projects to improve the diagnosis and/or care of patients with Chronic Intestinal Pseudo Obstruction, dysmotility or gastroparesis via our partners at the Pseudo Obstruction Research Trust (PORT).
How to apply
Please follow the link below to apply for a Bowel Research UK grant:
- Applications are encouraged from members of the Association of Coloproctology of Great Britain & Ireland
- Applications for work that exclusively uses experimental animals will not be prioritised
Share this page: